IHS Chemical Week

Regions :: North America :: U.S.

Chemtura beats estimates, but bromine weakness persists

3:52 PM MDT | July 30, 2013 | Vincent Valk

Chemtura’s second-quarter net income from continuing declined 11% year-on-year (YOY), to $47 million, or 47 cts/share, on sales down 1%, to $735 million, the company says. Adjusted net income declined 25%, to 40 cts/share, but beat analysts’ consensus estimate of 37 cts/share, as reported by Thomson Reuters. Chemtura recorded an overall net loss, of $93 million, due to a $146 million loss related to the sale of its antioxidants business. Results were mostly in line with Chemtura’s reported preliminary results, issued earlier this month...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa